Soumya Ranjan Mishra

Employment

• University of New Mexico Health Science Center Post doctoral Fellow
  2024 - Present
• National Institute of Technology Rourkela Research Scholar
  2018 - 2024

Education

• National Institute of Technology Rourkela PhD
  2018 - 2024
• Sambalpur University MSc
  2016 - 2018

Projects & Funding

Projects & funding information is unavailable.

Publications (23)

• PPA2 activates MTFP1-DNM1L fission signaling to govern mitochondrial proliferation and mitophagy
  Autophagy 2025 DOI: 10.1080/15548627.2025.2552900
  +Save
• ATG16L1 controls mammalian vacuolar proton ATPase
  Journal of Cell Biology 2025 DOI: 10.1083/jcb.202503166
  +Save
• SIRT1-activating butein inhibits arecoline-induced mitochondrial dysfunction through PGC1α and MTP18 in oral cancer
  Phytomedicine 2024 DOI: 10.1016/j.phymed.2024.155511
  +Save
• Autophagy for secretory protein: Therapeutic targets in cancer
  Advances in Protein Chemistry and Structural Biology 2023 DOI: 10.1016/bs.apcsb.2022.10.009
  +Save
• CLU (clusterin) promotes mitophagic degradation of MSX2 through an AKT-DNM1L/Drp1 axis to maintain SOX2-mediated stemness in oral cancer stem cells
  Autophagy 2023 DOI: 10.1080/15548627.2023.2178876
  +Save
• Stonin 2 activates lysosomal-mTOR axis for cell survival in oral cancer
  Toxicology in Vitro 2023 DOI: 10.1016/j.tiv.2023.105561
  +Save
• Autophagy-modulating phytochemicals in cancer therapeutics: Current evidences and future perspectives
  Seminars in Cancer Biology 2022 DOI: 10.1016/j.semcancer.2020.05.008
  +Save
• Inflammasomes in cancer: Effect of epigenetic and autophagic modulations
  Seminars in Cancer Biology 2022 DOI: 10.1016/j.semcancer.2020.09.013
  +Save
• PAX9 reactivation by inhibiting DNA methyltransferase triggers antitumor effect in oral squamous cell carcinoma
  Biochimica et Biophysica Acta - Molecular Basis of Disease 2022 DOI: 10.1016/j.bbadis.2022.166428
  +Save
• Mitochondrial rewiring through mitophagy and mitochondrial biogenesis in cancer stem cells: A potential target for anti-CSC cancer therapy
  Cancer Letters 2021 DOI: 10.1016/j.canlet.2020.10.036
  +Save